These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32467089)

  • 21. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
    Desjardin M; Luc G; Collet D; Zerbib F
    Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial.
    Bonavina L; DeMeester T; Fockens P; Dunn D; Saino G; Bona D; Lipham J; Bemelman W; Ganz RA
    Ann Surg; 2010 Nov; 252(5):857-62. PubMed ID: 21037442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease.
    Schwameis K; Nikolic M; Morales Castellano DG; Steindl A; Macheck S; Kristo I; Zörner B; Schoppmann SF
    World J Surg; 2018 Oct; 42(10):3263-3269. PubMed ID: 29619511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study.
    Moawad FJ; Betteridge JD; Boger JA; Cheng FK; Belle LS; Chen YJ; Maydonovitch CL; Wong RK
    Aliment Pharmacol Ther; 2013 May; 37(10):1011-8. PubMed ID: 23560727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Impedance-pH Testing on Medications Reliably Identify Patients with GERD as Defined by Pathologic Esophageal Acid Exposure off Medications?
    Ward MA; Dunst CM; Glasgow ME; Teitelbaum EN; Abdelmoaty WF; Reavis KM; Swanstrӧm LL; DeMeester SR
    J Gastrointest Surg; 2019 Jul; 23(7):1301-1308. PubMed ID: 30859425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified inspiratory muscle training (m-IMT) as promising treatment for gastro-oesophageal reflux disease (GERD).
    Moffa A; Oliveto G; Matteo FD; Baptista P; Cárdenas A; Cassano M; Casale M
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(2):65-69. PubMed ID: 31103135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
    Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E
    Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Analysis of Laparoscopic Fundoplication and Magnetic Sphincter Augmentation for the Treatment of Medically Refractory GERD.
    Richards WO; McRae C
    Am Surg; 2018 Nov; 84(11):1762-1767. PubMed ID: 30747630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of medical and surgical therapy of GERD: predictive role of quality of life scores and instrumental evaluation.
    Rossetti G; Limongelli P; Cimmino M; Napoletano D; Bondanese MC; Romano G; Pratilas M; Guerriero L; Orlando F; Conzo G; Amato B; Docimo G; Tolone S; Brusciano L; Docimo L; Fei L
    Int J Surg; 2014; 12 Suppl 1():S112-6. PubMed ID: 24946311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
    Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux.
    Ganz RA; Edmundowicz SA; Taiganides PA; Lipham JC; Smith CD; DeVault KR; Horgan S; Jacobsen G; Luketich JD; Smith CC; Schlack-Haerer SC; Kothari SN; Dunst CM; Watson TJ; Peters J; Oelschlager BK; Perry KA; Melvin S; Bemelman WA; Smout AJ; Dunn D
    Clin Gastroenterol Hepatol; 2016 May; 14(5):671-7. PubMed ID: 26044316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease.
    Warren HF; Reynolds JL; Lipham JC; Zehetner J; Bildzukewicz NA; Taiganides PA; Mickley J; Aye RW; Farivar AS; Louie BE
    Surg Endosc; 2016 Aug; 30(8):3289-96. PubMed ID: 26541740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD.
    Ribolsi M; Savarino E; Frazzoni M; Cicala M
    Dig Liver Dis; 2023 Jun; 55(6):721-726. PubMed ID: 36572569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes and Predictors of Favorable Result after Laparoscopic Magnetic Sphincter Augmentation: Single-Institution Experience with More than 500 Patients.
    Ayazi S; Zheng P; Zaidi AH; Chovanec K; Salvitti M; Newhams K; Hoppo T; Jobe BA
    J Am Coll Surg; 2020 May; 230(5):733-743. PubMed ID: 32081749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.